19th Conference of the International Society of Geriatric Oncology

www.siogconference.org

 

Breast
02:46

19th Conference of the International Society of Geriatric Oncology

The Prevalence of Luminal B Subtype Is Higher in Older Postmenopausal Women With ER+/HER2- Breast Cancer and Is Associated With Inferior Outcomes

FEATURING Matthew N. Mills
  • 21 views
  • December 27, 2019
03:10

19th Conference of the International Society of Geriatric Oncology

Cytoplasmic Cyclin E Is an Exquisite Marker of Tumour Biology in Older Women With Primary Breast Cancer

FEATURING Ruth Mary Parks
  • 13 views
  • December 27, 2019
03:02

19th Conference of the International Society of Geriatric Oncology

79 y/o Female w/ HER+ Breast Cancer: Questions on (Neo)Adjuvant Chemo, Radiotherapy, Trastuzumab and Adjuvant Hormonal Therapy

FEATURING Enrique Soto Perez De Celis
  • 22 views
  • December 27, 2019
08:33

19th Conference of the International Society of Geriatric Oncology

(Neo)Adjuvant Approach to HER2+ Breast Cancer in Older Adults: De-escalation Strategies (Taxane Only Regimens, Shorter Duration Trastuzumab, Anti-HER2 Without Chemo, etc.)

FEATURING Hans Wildiers
  • 886 views
  • December 24, 2019
  • 2
09:47

19th Conference of the International Society of Geriatric Oncology

Radiation Therapy in HER+ Breast Cancer: Relative Benefits Are Constant and Relate to Biology and Absolute Benefits Are Often Small

FEATURING Richard Simcock
  • 22 views
  • December 27, 2019
02:56

19th Conference of the International Society of Geriatric Oncology

89 y/o Female w/ TNBC: Questions on (Neo)Adjuvant Chemo, Radiation Therapy, Genetic Assessment, and the Effects of Surgery

FEATURING Enrique Soto Perez De Celis
  • 21 views
  • December 27, 2019
09:44

19th Conference of the International Society of Geriatric Oncology

Breast Cancer Surgery Impacts on Functional Status and Independence, But Evidence Base Weak

FEATURING Ruth Mary Parks
  • 13 views
  • December 27, 2019
09:33

19th Conference of the International Society of Geriatric Oncology

Chemo Regimens in Older Adults w/ TNBC: Sequential Anthracycline / Taxane Based Regimens for High-Risk, Docetaxel / Cyclophosphamide for Lower-Risk

FEATURING Nicolo Battisti
  • 746 views
  • December 24, 2019
  • 5
03:40

19th Conference of the International Society of Geriatric Oncology

Serious Adverse Events Among Older Patients in the ALTTO Trial Comparing Anti-HER2 w/ Lapatinib & Trastuzumab, Their sequence or Combination in the Adjuvant Treatment of HER2+ Early Breast Cancer

FEATURING Lissandra Dal Lago
  • 29 views
  • December 27, 2019